Sean Godbout's most recent trade in Biogen Inc was a trade of 26 Restricted Stock Unit done . Disclosure was reported to the exchange on Oct. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen | Sean Godbout | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2025 | 26 | 27 | - | - | Restricted Stock Unit | |
| Biogen | Sean Godbout | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2025 | 26 | 502 (0%) | 0% | 0 | Common Stock | |
| Biogen | Sean Godbout | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 155.25 per share. | 02 Oct 2025 | 8 | 494 (0%) | 0% | 155.3 | 1,242 | Common Stock |
| Biogen | Sean Godbout | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 545 | 545 | - | - | Restricted Stock Unit |